Zoom shows strong profitability and cash flow despite modest growth and cautious guidance, weighed by SBC and macro risks.

The pharma major's consolidated net profit jumped 23.04% to Rs 662 crore in Q4 FY25 as against Rs 538 crore recorded in Q4 FY24.

MSTC, in an exchange filing, today, informed the bourses that the meeting of the Board of Directors of the company is ...

Down 80% from all-time highs, this top TSX stock trades at a sizeable discount given the company's steady growth estimates.

Tesla stock is down in 2025, but has rebounded on robotaxi hopes, clearing a highly aggressive entry on May 9 and continuing ...